Maduri V, Eresha J, Dulani S, Pujitha W
BMC Pediatr. 2025; 25(1):144.
PMID: 40011867
PMC: 11863752.
DOI: 10.1186/s12887-025-05484-0.
Taniguchi H, Ueda M, Kobayashi Y, Shima T
Sci Rep. 2025; 15(1):2606.
PMID: 39838114
PMC: 11751101.
DOI: 10.1038/s41598-025-86424-x.
Fujii I, Matsumoto N, Ogawa M, Konishi A, Kaneko M, Watanabe Y
Diagnostics (Basel). 2024; 14(22).
PMID: 39594250
PMC: 11593288.
DOI: 10.3390/diagnostics14222585.
Mukherjee S, Mukherjee S, Kwok C, Phillips A
World J Hepatol. 2024; 16(8):1120-1130.
PMID: 39221103
PMC: 11362911.
DOI: 10.4254/wjh.v16.i8.1120.
Abrams E, Jao J, Madlala H, Zerbe A, Catalano P, Gerschenson M
PLoS One. 2024; 19(8):e0307296.
PMID: 39159183
PMC: 11332920.
DOI: 10.1371/journal.pone.0307296.
Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Fogacci F, Giovannini M, Di Micoli V, Grandi E, Borghi C, Cicero A
Nutrients. 2024; 16(15).
PMID: 39125336
PMC: 11313833.
DOI: 10.3390/nu16152454.
Prevalence, characteristics, and risk factors of non-alcoholic fatty liver disease in North East of Iran: a population-based study.
AkbariRad M, Pezeshki Rad M, Nobakht H, Moodi Ghalibaf A, Firoozi A, Torshizian A
BMC Gastroenterol. 2024; 24(1):212.
PMID: 38926664
PMC: 11210030.
DOI: 10.1186/s12876-024-03302-y.
Dietary characteristics associated with the risk of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease in non-obese Japanese participants: A cross-sectional study.
Taniguchi H, Ueda M, Sano F, Kobayashi Y, Shima T
JGH Open. 2024; 8(5):e13082.
PMID: 38779132
PMC: 11109997.
DOI: 10.1002/jgh3.13082.
The association between platelet-related parameters and nonalcoholic fatty liver disease in a metabolically healthy nonobese population.
Choe E, Kang H
Sci Rep. 2024; 14(1):6118.
PMID: 38480828
PMC: 10937929.
DOI: 10.1038/s41598-024-56796-7.
Liver Fat Storage Is a Better Predictor of Coronary Artery Disease than Visceral Fat.
Basheer M, Saad E, Jeries H, Assy N
Metabolites. 2023; 13(8).
PMID: 37623840
PMC: 10456344.
DOI: 10.3390/metabo13080896.
Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y, Zhang Q, Li H, Zhou G, Shi P, Zhang X
Front Endocrinol (Lausanne). 2023; 14:1098078.
PMID: 37214248
PMC: 10198261.
DOI: 10.3389/fendo.2023.1098078.
Fibrosis score 4 index has an independent relationship with coronary artery diseases in patients with metabolic-associated fatty liver disease.
Namakchian M, Rabizadeh S, Seifouri S, Asadigandomani H, Arab Bafrani M, Seifouri K
Diabetol Metab Syndr. 2023; 15(1):57.
PMID: 36964605
PMC: 10039491.
DOI: 10.1186/s13098-023-01031-y.
The role of platelet-related parameters for the prediction of NAFLD in OSAHS patients.
Chen M, Wang B, Huang J, Zhao J, Chen J, Chen G
BMC Pulm Med. 2022; 22(1):487.
PMID: 36566219
PMC: 9790114.
DOI: 10.1186/s12890-022-02291-6.
Lower Circulating Leptin Levels Are Related to Non-Alcoholic Fatty Liver Disease in Children With Obesity.
Brandt S, von Schnurbein J, Denzer C, Kratzer W, Wabitsch M
Front Endocrinol (Lausanne). 2022; 13:881982.
PMID: 35677722
PMC: 9169562.
DOI: 10.3389/fendo.2022.881982.
Equations for predicting DXA-measured visceral adipose tissue mass based on BMI or weight in adults.
Song X, Wu H, Zhang W, Wang B, Sun H
Lipids Health Dis. 2022; 21(1):45.
PMID: 35578238
PMC: 9109344.
DOI: 10.1186/s12944-022-01652-8.
The Role of Aspartate Transaminase to Platelet Ratio Index (APRI) for the Prediction of Non-Alcoholic Fatty Liver Disease (NAFLD) in Severely Obese Children and Adolescents.
Rigamonti A, Bondesan A, Rondinelli E, Cella S, Sartorio A
Metabolites. 2022; 12(2).
PMID: 35208229
PMC: 8879448.
DOI: 10.3390/metabo12020155.
Non-Alcoholic Fatty Liver Disease and Hypokalemia in Primary Aldosteronism Among Chinese Population.
Chen Y, Chen X, Chen Q, Yu C
Front Endocrinol (Lausanne). 2021; 12:565714.
PMID: 33967948
PMC: 8101285.
DOI: 10.3389/fendo.2021.565714.
Attenuation Imaging with Ultrasound as a Novel Evaluation Method for Liver Steatosis.
Hsu P, Wu L, Yen H, Huang H, Chen Y, Su P
J Clin Med. 2021; 10(5).
PMID: 33801163
PMC: 7957732.
DOI: 10.3390/jcm10050965.
Decreased plasma n6 : n3 polyunsaturated fatty acids ratio interacting with high C-peptide promotes non-alcoholic fatty liver disease in type 2 diabetes patients.
Luo H, Zhao M, Feng X, Gao X, Hong M, Liu M
J Diabetes Investig. 2020; 12(7):1263-1271.
PMID: 33244871
PMC: 8264392.
DOI: 10.1111/jdi.13469.
Carbon tetrachloride (CCl) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF).
Zhang G, Wang X, Chung T, Ye W, Hodge L, Zhang L
BMC Gastroenterol. 2020; 20(1):339.
PMID: 33059584
PMC: 7560288.
DOI: 10.1186/s12876-020-01467-w.